ABSTRACT
Advancing age is associated with a decline in the integrity of physical barriers and
protection against invading pathogens, and age-related changes in the immune system
are associated with increased susceptibility to the emergence of autoimmune phenomena,
neoplasia, and infections. Respiratory tract infections can occur at any age, but
the incidence of lower respiratory tract infections increases significantly with advanced
age such that pneumonia is a leading cause of illness and death in the elderly. Changes
in lung physiology and immune function coupled with inflammation induced by environmental
exposures or endogenous factors such as predisposition to aspiration may, in part,
account for the increase in susceptibility to respiratory infections. Additionally,
age-associated alterations in immune regulation (“immunosenescence”) with dysregulation
of lung homeostasis may allow low-grade inflammatory changes that lead to anatomical
and physiological changes that characterize the senescent lung. The presence of disease
states in elderly populations, such as chronic obstructive pulmonary disease (COPD)
or nonpulmonary organ system diseases, may increase the likelihood of developing severe
respiratory infections. This article examines age-related changes in immune function
that predispose elderly individuals to lung remodeling but focuses especially on lower
respiratory tract infections. It will discuss risk factors, identify pathogens that
typically lead to respiratory infections in the elderly, and review current approaches
to treatment and prevention of respiratory infections in the elderly population.
KEYWORDS
Lung - aging - aged - elderly - pneumonia - immunosenescence - immunity
REFERENCES
1
Pawelec G, Larbi A.
Immunity and ageing in man: Annual Review 2006/2007.
Exp Gerontol.
2008;
43
34-38
2
Hasler P, Zouali M.
Immune receptor signaling, aging, and autoimmunity.
Cell Immunol.
2005;
233
102-108
3
Meyer K C.
Aging.
Proc Am Thorac Soc.
2005;
2
433-439
4
Franceschi C, Bonafè M, Valensin S.
Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic
immunity, and the filling of immunological space.
Vaccine.
2000;
18
1717-1720
5
Franceschi C, Bonafè M.
Centenarians as a model for healthy aging.
Biochem Soc Trans.
2003;
31
457-461
6
Franceschi C, Monti D, Sansoni P, Cossarizza A.
The immunology of exceptional individuals: the lesson of centenarians.
Immunol Today.
1995;
16
12-16
7 Meyer K C.
The aging human lung: age-associated changes in structure and function . In: Conn PM Handbook of Models for Human Aging. Boston, MA; Elsevier Academic 2006:
727-734
8
Thompson A B, Scholer S G, Daughton D M, Potter J F, Rennard S I.
Altered epithelial lining fluid parameters in old normal individuals.
J Gerontol.
1992;
47
M171-M176
9
Meyer K C, Ershler W, Rosenthal N S, Lu X G, Peterson K.
Immune dysregulation in the aging human lung.
Am J Respir Crit Care Med.
1996;
153
1072-1079
10
Meyer K C, Rosenthal N S, Soergel P, Peterson K.
Neutrophils and low-grade inflammation in the seemingly normal aging human lung.
Mech Ageing Dev.
1998;
104
169-181
11
Meyer K C, Soergel P.
Variation of bronchoalveolar lymphocyte phenotypes with age in the physiologically
normal human lung.
Thorax.
1999;
54
697-700
12
Meyer K C, Cardoni A, Xiang Z Z.
Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects
and patients with diffuse parenchymal lung disease.
J Lab Clin Med.
2000;
135
332-338
13
Harms K L, Chen X.
Histone deacetylase 2 modulates p53 transcriptional activities through regulation
of p53-DNA binding activity.
Cancer Res.
2007;
67
3145-3152
14
Delves P J, Roitt I M.
The immune system: first of two parts.
N Engl J Med.
2000;
343
37-49
15
Delves P J, Roitt I M.
The immune system: second of two parts.
N Engl J Med.
2000;
343
108-117
16
Medzhitov R, Janeway Jr C J.
Innate immunity.
N Engl J Med.
2000;
343
338-344
17
Monie T P, Bryant C E, Gay N J.
Activating immunity: lessons from the TLRs and NLRs.
Trends Biochem Sci.
2009;
34
553-561
18
Medzhitov R, Janeway Jr C.
Innate immune recognition: mechanisms and pathways.
Immunol Rev.
2000;
173
89-97
19
Zhang P, Summer W R, Bagby G J, Nelson S.
Innate immunity and pulmonary host defense.
Immunol Rev.
2000;
173
39-51
20
Corberand J, Ngyen F, Laharrague P et al..
Polymorphonuclear functions and aging in humans.
J Am Geriatr Soc.
1981;
29
391-397
21
Fu Y K, Arkins S, Li Y M, Dantzer R, Kelley K W.
Reduction in superoxide anion secretion and bactericidal activity of neutrophils from
aged rats: reversal by the combination of gamma interferon and growth hormone.
Infect Immun.
1994;
62
1-8
22
Tortorella C, Ottolenghi A, Pugliese P, Jirillo E, Antonaci S.
Relationship between respiratory burst and adhesiveness capacity in elderly polymorphonuclear
cells.
Mech Ageing Dev.
1993;
69
53-63
23
Fülöp Jr T, Fouquet C, Allaire P et al..
Changes in apoptosis of human polymorphonuclear granulocytes with aging.
Mech Ageing Dev.
1997;
96
15-34
24
Tortorella C, Piazzolla G, Spaccavento F, Pece S, Jirillo E, Antonaci S.
Spontaneous and Fas-induced apoptotic cell death in aged neutrophils.
J Clin Immunol.
1998;
18
321-329
25
Szakal A K, Kapasi Z F, Masuda A, Tew J G.
Follicular dendritic cells in the alternative antigen transport pathway: microenvironment,
cellular events, age and retrovirus related alterations.
Semin Immunol.
1992;
4
257-265
26
Pietschmann P, Hahn P, Kudlacek S, Thomas R, Peterlik M.
Surface markers and transendothelial migration of dendritic cells from elderly subjects.
Exp Gerontol.
2000;
35
213-224
27
Steger M M, Maczek C, Grubeck-Loebenstein B.
Morphologically and functionally intact dendritic cells can be derived from the peripheral
blood of aged individuals.
Clin Exp Immunol.
1996;
105
544-550
28
Lung T L, Saurwein-Teissl M, Parson W, Schönitzer D, Grubeck-Loebenstein B.
Unimpaired dendritic cells can be derived from monocytes in old age and can mobilize
residual function in senescent T cells.
Vaccine.
2000;
18
1606-1612
29
Shodell M, Siegal F P.
Circulating, interferon-producing plasmacytoid dendritic cells decline during human
ageing.
Scand J Immunol.
2002;
56
518-521
30
Davila D R, Edwards III C K, Arkins S, Simon J, Kelley K W.
Interferon-gamma-induced priming for secretion of superoxide anion and tumor necrosis
factor-alpha declines in macrophages from aged rats.
FASEB J.
1990;
4
2906-2911
31
Alvarez E, Machado A, Sobrino F, Santa Maria C.
Nitric oxide and superoxide anion production decrease with age in resident and activated
rat peritoneal macrophages.
Cell Immunol.
1996;
169
152-155
32
Lavie L, Weinreb O, Gershon D.
Age-related alterations in superoxide anion generation in mouse peritoneal macrophages
studied by repeated stimulations and heat shock treatment.
J Cell Physiol.
1992;
152
382-388
33
Khare P D, Dhawan R, Chaturvedi U C.
Identification and characterization of receptor for dengue virus-induced macrophage
cytotoxin.
Indian J Exp Biol.
1996;
34
652-657
34
Chen L C, Pace J L, Russell S W, Morrison D C.
Altered regulation of inducible nitric oxide synthase expression in macrophages from
senescent mice.
Infect Immun.
1996;
64
4288-4298
35
Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S.
Cutting edge: impaired Toll-like receptor expression and function in aging.
J Immunol.
2002;
169
4697-4701
36
Boehmer E D, Goral J, Faunce D E, Kovacs E J.
Age-dependent decrease in Toll-like receptor 4-mediated proinflammatory cytokine production
and mitogen-activated protein kinase expression.
J Leukoc Biol.
2004;
75
342-349
37
Swift M E, Burns A L, Gray K L, DiPietro L A.
Age-related alterations in the inflammatory response to dermal injury.
J Invest Dermatol.
2001;
117
1027-1035
38
Ashcroft G S, Horan M A, Ferguson M W.
Aging alters the inflammatory and endothelial cell adhesion molecule profiles during
human cutaneous wound healing.
Lab Invest.
1998;
78
47-58
39
McNerlan S E, Rea I M, Alexander H D, Morris T C.
Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy
aging.
J Clin Immunol.
1998;
18
31-38
40
Ogata K, Yokose N, Tamura H et al..
Natural killer cells in the late decades of human life.
Clin Immunol Immunopathol.
1997;
84
269-275
41
Miyaji C, Watanabe H, Toma H et al..
Functional alteration of granulocytes, NK cells, and natural killer T cells in centenarians.
Hum Immunol.
2000;
61
908-916
42
Poynter M E, Mu H H, Chen X P, Daynes R A.
Activation of NK1.1 + T cells in vitro and their possible role in age-associated changes
in inducible IL-4 production.
Cell Immunol.
1997;
179
22-29
43
Dubey D P, Husain Z, Levitan E et al..
The MHC influences NK and NKT cell functions associated with immune abnormalities
and lifespan.
Mech Ageing Dev.
2000;
113
117-134
44
Flurkey K, Stadecker M, Miller R A.
Memory T lymphocyte hyporesponsiveness to non-cognate stimuli: a key factor in age-related
immunodeficiency.
Eur J Immunol.
1992;
22
931-935
45
Naylor K, Li G, Vallejo A N et al..
The influence of age on T cell generation and TCR diversity.
J Immunol.
2005;
174
7446-7452
46
Swain S, Clise-Dwyer K, Haynes L.
Homeostasis and the age-associated defect of CD4 T cells.
Semin Immunol.
2005;
17
370-377
47
Cakman I, Rohwer J, Schütz R M, Kirchner H, Rink L.
Dysregulation between TH1 and TH2 T cell subpopulations in the elderly.
Mech Ageing Dev.
1996;
87
197-209
48
Zhou T, Edwards III C K, Mountz J D.
Prevention of age-related T cell apoptosis defect in CD2-fas-transgenic mice.
J Exp Med.
1995;
182
129-137
49
Jackola D R, Ruger J K, Miller R A.
Age-associated changes in human T cell phenotype and function.
Aging (Milano).
1994;
6
25-34
50
McKenna R W, Washington L T, Aquino D B, Picker L J, Kroft S H.
Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive
bone marrow specimens by 4-color flow cytometry.
Blood.
2001;
98
2498-2507
51
Dailey R W, Eun S Y, Russell C E, Vogel L A.
B cells of aged mice show decreased expansion in response to antigen, but are normal
in effector function.
Cell Immunol.
2001;
214
99-109
52
Doria G, D'Agostaro G, Poretti A.
Age-dependent variations of antibody avidity.
Immunology.
1978;
35
601-611
53
Yang X, Stedra J, Cerny J.
Relative contribution of T and B cells to hypermutation and selection of the antibody
repertoire in germinal centers of aged mice.
J Exp Med.
1996;
183
959-970
54
Ferguson F G, Wikby A, Maxson P, Olsson J, Johansson B.
Immune parameters in a longitudinal study of a very old population of Swedish people:
a comparison between survivors and nonsurvivors.
J Gerontol A Biol Sci Med Sci.
1995;
50
B378-B382
55
Butcher S K, Lord J M.
Stress responses and innate immunity: aging as a contributory factor.
Aging Cell.
2004;
3
151-160
56
Verbeken E K, Cauberghs M, Mertens I, Clement J, Lauweryns J M, Van de Woestijne K P.
The senile lung: comparison with normal and emphysematous lungs. 1. Structural aspects.
Chest.
1992;
101
793-799
57
Fishman A P.
One hundred years of chronic obstructive pulmonary disease.
Am J Respir Crit Care Med.
2005;
171
941-948
58
Mittman C, Edelman N H, Norris A H, Shock N W.
Relationship between chest wall and pulmonary compliance and age.
J Appl Physiol.
1965;
20
1211-1216
59
Turner J M, Mead J, Wohl M E.
Elasticity of human lungs in relation to age.
J Appl Physiol.
1968;
25
664-671
60
Hancock D B, Eijgelsheim M, Wilk J B et al..
Meta-analyses of genome-wide association studies identify multiple loci associated
with pulmonary function.
Nat Genet.
2010;
42
45-52
61
Edge J R, Millard F J, Reid L, Simon G.
The radiographic appearances of the chest in persons of advanced age.
Br J Radiol.
1964;
37
769-774
62
Tolep K, Kelsen S G.
Effect of aging on respiratory skeletal muscles.
Clin Chest Med.
1993;
14
363-378
63
Polkey M I, Harris M L, Hughes P D et al..
The contractile properties of the elderly human diaphragm.
Am J Respir Crit Care Med.
1997;
155
1560-1564
64
Evans S A, Watson L, Hawkins M, Cowley A J, Johnston I D, Kinnear W J.
Respiratory muscle strength in chronic heart failure.
Thorax.
1995;
50
625-628
65
Mancini D M, Henson D, LaManca J, Levine S.
Respiratory muscle function and dyspnea in patients with chronic congestive heart
failure.
Circulation.
1992;
86
909-918
66
Verdery R B.
Malnutrition and chronic inflammation: causes or effects of frailty.
Aging Clin Exp Res.
1992;
4
262-263
67
Shaker R, Ren J L, Bardan E et al..
Pharyngoglottal closure reflex: characterization in healthy young, elderly and dysphagic
patients with predeglutitive aspiration.
Gerontology.
2003;
49
12-20
68
Nakayama K, Jia Y X, Hirai H et al..
Acid stimulation reduces bactericidal activity of surface liquid in cultured human
airway epithelial cells.
Am J Respir Cell Mol Biol.
2002;
26
105-113
69
Chouinard J.
Dysphagia in Alzheimer disease: a review.
J Nutr Health Aging.
2000;
4
214-217
70
Ruiz M, Ewig S, Marcos M A et al..
Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.
Am J Respir Crit Care Med.
1999;
160
397-405
71
Puchelle E, Zahm J M, Bertrand A.
Influence of age on bronchial mucociliary transport.
Scand J Respir Dis.
1979;
60
307-313
72
Ho J C, Chan K N, Hu W H et al..
The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure
of respiratory cilia.
Am J Respir Crit Care Med.
2001;
163
983-988
73
Plowden J, Renshaw-Hoelscher M, Engleman C, Katz J, Sambhara S.
Innate immunity in aging: impact on macrophage function.
Aging Cell.
2004;
3
161-167
74
Koike E, Kobayashi T, Mochitate K, Murakami M.
Effect of aging on nitric oxide production by rat alveolar macrophages.
Exp Gerontol.
1999;
34
889-894
75
Corsini E, Battaini F, Lucchi L et al..
A defective protein kinase C anchoring system underlying age-associated impairment
in TNF-alpha production in rat macrophages.
J Immunol.
1999;
163
3468-3473
76
Zissel G, Schlaak M, Müller-Quernheim J.
Age-related decrease in accessory cell function of human alveolar macrophages.
J Investig Med.
1999;
47
51-56
77
Corsini E, Di Paola R, Viviani B et al..
Increased carrageenan-induced acute lung inflammation in old rats.
Immunology.
2005;
115
253-261
78
Ito K, Barnes P J.
COPD as a disease of accelerated lung aging.
Chest.
2009;
135
173-180
79
Fletcher C, Peto R.
The natural history of chronic airflow obstruction.
BMJ.
1977;
1
1645-1648
80
Harman D.
Free radical theory of aging: an update: increasing the functional life span.
Ann N Y Acad Sci.
2006;
1067
10-21
81
Promislow D E.
DNA repair and the evolution of longevity: a critical analysis.
J Theor Biol.
1994;
170
291-300
82
Gupte A A, Bomhoff G L, Geiger P C.
Age-related differences in skeletal muscle insulin signaling: the role of stress kinases
and heat shock proteins.
J Appl Physiol.
2008;
105
839-848
83
Rahman I, Adcock I M.
Oxidative stress and redox regulation of lung inflammation in COPD.
Eur Respir J.
2006;
28
219-242
84
Ito K.
Does lung aging have an impact on chronic obstructive pulmonary disease?.
J Organ Dysfunction.
2007;
3
204-220
85
Grubisha O, Smith B C, Denu J M.
Small molecule regulation of Sir2 protein deacetylases.
FEBS J.
2005;
272
4607-4616
86
Suga T, Kurabayashi M, Sando Y et al..
Disruption of the klotho gene causes pulmonary emphysema in mice: defect in maintenance
of pulmonary integrity during postnatal life.
Am J Respir Cell Mol Biol.
2000;
22
26-33
87
Maruyama N, Ishigami A, Kuramoto M et al..
Senescence marker protein-30 knockout mouse as an aging model.
Ann N Y Acad Sci.
2004;
1019
383-387
88
Vogel H, Lim D S, Karsenty G, Finegold M, Hasty P.
Deletion of Ku86 causes early onset of senescence in mice.
Proc Natl Acad Sci U S A.
1999;
96
10770-10775
89
Sato T, Seyama K, Sato Y et al..
Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and
smoking.
Am J Respir Crit Care Med.
2006;
174
530-537
90
Collins K, Mitchell J R.
Telomerase in the human organism.
Oncogene.
2002;
21
564-579
91
Jiang H, Ju Z, Rudolph K L.
Telomere shortening and ageing.
Z Gerontol Geriatr.
2007;
40
314-324
92
von Zglinicki T.
Oxidative stress shortens telomeres.
Trends Biochem Sci.
2002;
27
339-344
93
Tsuji T, Aoshiba K, Nagai A.
Alveolar cell senescence in patients with pulmonary emphysema.
Am J Respir Crit Care Med.
2006;
174
886-893
94
Morlá M, Busquets X, Pons J, Sauleda J, MacNee W, Agustí A G.
Telomere shortening in smokers with and without COPD.
Eur Respir J.
2006;
27
525-528
95
Garcia C K, Wright W E, Shay J W.
Human diseases of telomerase dysfunction: insights into tissue aging.
Nucleic Acids Res.
2007;
35
7406-7416
96
Alder J K, Chen J J, Lancaster L et al..
Short telomeres are a risk factor for idiopathic pulmonary fibrosis.
Proc Natl Acad Sci U S A.
2008;
105
13051-13056
97
Tsakiri K D, Cronkhite J T, Kuan P J et al..
Adult-onset pulmonary fibrosis caused by mutations in telomerase.
Proc Natl Acad Sci U S A.
2007;
104
7552-7557
98
Hogg J C, van Eeden S.
Pulmonary and systemic response to atmospheric pollution.
Respirology.
2009;
14
336-346
99
Oberdörster G.
Pulmonary effects of inhaled ultrafine particles.
Int Arch Occup Environ Health.
2001;
74
1-8
100
Neupane B, Jerrett M, Burnett R T, Marrie T, Arain A, Loeb M.
Long-term exposure to ambient air pollution and risk of hospitalization with community-acquired
pneumonia in older adults.
Am J Respir Crit Care Med.
2010;
181
47-53
101
Zanobetti A, Bind M A, Schwartz J.
Particulate air pollution and survival in a COPD cohort.
Environ Health.
2008;
7
48
102
Mora A L, Rojas M.
Aging and lung injury repair: a role for bone marrow derived mesenchymal stem cells.
J Cell Biochem.
2008;
105
641-647
103
Ruzankina Y, Asare A, Brown E J.
Replicative stress, stem cells and aging.
Mech Ageing Dev.
2008;
129
460-466
104
Butcher S K, Lord J M.
Stress responses and innate immunity: aging as a contributory factor.
Aging Cell.
2004;
3
151-160
105
Goncharova N D, Lapin B A.
Age-related endocrine dysfunction in nonhuman primates.
Ann N Y Acad Sci.
2004;
1019
321-325
106
Grimble R F.
Inflammatory response in the elderly.
Curr Opin Clin Nutr Metab Care.
2003;
6
21-29
107
Barnes P J.
Corticosteroid resistance in airway disease.
Proc Am Thorac Soc.
2004;
1
264-268
108
Lages C S, Suffia I, Velilla P A et al..
Functional regulatory T cells accumulate in aged hosts and promote chronic infectious
disease reactivation.
J Immunol.
2008;
181
1835-1848
109
Weyand C M, Brandes J C, Schmidt D, Fulbright J W, Goronzy J J.
Functional properties of CD4 + CD28−T cells in the aging immune system.
Mech Ageing Dev.
1998;
102
131-147
110
Bryl E, Vallejo A N, Weyand C M, Goronzy J J.
Down-regulation of CD28 expression by TNF-alpha.
J Immunol.
2001;
167
3231-3238
111
Gilani S R, Vuga L J, Lindell K O et al..
CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses
of patients with idiopathic pulmonary fibrosis.
PLoS One.
2010;
5
e8959
112
Zalacain R, Torres A.
Pneumonia in the elderly.
Clin Pulm Med.
2004;
11
210-218
113
Treanor J, Falsey A.
Respiratory viral infections in the elderly.
Antiviral Res.
1999;
44
79-102
114
Metlay J P, Schulz R, Li Y H et al..
Influence of age on symptoms at presentation in patients with community-acquired pneumonia.
Arch Intern Med.
1997;
157
1453-1459
115
Niederman M S, Mandell L A, Anzueto A American Thoracic Society et al.
Guidelines for the management of adults with community-acquired pneumonia: diagnosis,
assessment of severity, antimicrobial therapy, and prevention.
Am J Respir Crit Care Med.
2001;
163
1730-1754
116
Fine M J, Auble T E, Yealy D M et al..
A prediction rule to identify low-risk patients with community-acquired pneumonia.
N Engl J Med.
1997;
336
243-250
117
Meehan T P, Fine M J, Krumholz H M et al..
Quality of care, process, and outcomes in elderly patients with pneumonia.
JAMA.
1997;
278
2080-2084
118
Falsey A R, Walsh E E.
Viral pneumonia in older adults.
Clin Infect Dis.
2006;
42
518-524
119
Thompson W W, Shay D K, Weintraub E et al..
Influenza-associated hospitalizations in the United States.
JAMA.
2004;
292
1333-1340
120
Bradley S F. Long-Term-Care Committee of the Society for Healthcare Epidemiology of
America .
Prevention of influenza in long-term-care facilities.
Infect Control Hosp Epidemiol.
1999;
20
629-637
121
Falsey A R, Hennessey P A, Formica M A, Cox C, Walsh E E.
Respiratory syncytial virus infection in elderly and high-risk adults.
N Engl J Med.
2005;
352
1749-1759
122
Looney R J, Falsey A R, Walsh E, Campbell D.
Effect of aging on cytokine production in response to respiratory syncytial virus
infection.
J Infect Dis.
2002;
185
682-685
123
Hicks L A, Shepard C W, Britz P H et al..
Two outbreaks of severe respiratory disease in nursing homes associated with rhinovirus.
J Am Geriatr Soc.
2006;
54
284-289
124
Louie J K, Yagi S, Nelson F A et al..
Rhinovirus outbreak in a long term care facility for elderly persons associated with
unusually high mortality.
Clin Infect Dis.
2005;
41
262-265
125
Mosser A G, Vrtis R, Burchell L et al..
Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues.
Am J Respir Crit Care Med.
2005;
171
645-651
126
Laforce F M, Hopkins J, Trow R, Wang W L.
Human oral defenses against gram-negative rods.
Am Rev Respir Dis.
1976;
114
929-935
127
Smaldone G C.
Deposition and clearance: unique problems in the proximal airways and oral cavity
in the young and elderly.
Respir Physiol.
2001;
128
33-38
128
Palmer L B, Albulak K, Fields S, Filkin A M, Simon S, Smaldone G C.
Oral clearance and pathogenic oropharyngeal colonization in the elderly.
Am J Respir Crit Care Med.
2001;
164
464-468
129
Ayars G H, Altman L C, Fretwell M D.
Effect of decreased salivation and pH on the adherence of Klebsiella species to human buccal epithelial cells.
Infect Immun.
1982;
38
179-182
130
Kikuchi R, Watabe N, Konno T, Mishina N, Sekizawa K, Sasaki H.
High incidence of silent aspiration in elderly patients with community-acquired pneumonia.
Am J Respir Crit Care Med.
1994;
150
251-253
131
Matsuse T, Oka T, Kida K, Fukuchi Y.
Importance of diffuse aspiration bronchiolitis caused by chronic occult aspiration
in the elderly.
Chest.
1996;
110
1289-1293
132
Nakayama K, Jia Y X, Hirai H et al..
Acid stimulation reduces bactericidal activity of surface liquid in cultured human
airway epithelial cells.
Am J Respir Cell Mol Biol.
2002;
26
105-113
133
Riquelme R, Torres A, El-Ebiary M et al..
Community-acquired pneumonia in the elderly: a multivariate analysis of risk and prognostic
factors.
Am J Respir Crit Care Med.
1996;
154
1450-1455
134
Lesourd B M.
Nutrition: a major factor influencing immunity in the elderly.
J Nutr Health Aging.
2004;
8
28-37
135
Yeh S S, Schuster M W.
Geriatric cachexia: the role of cytokines.
Am J Clin Nutr.
1999;
70
183-197
136
Pamuk E R, Williamson D F, Serdula M K, Madans J, Byers T E.
Weight loss and subsequent death in a cohort of U.S. adults.
Ann Intern Med.
1993;
119(7 Pt 2)
744-748
137
Maffei M, Halaas J, Ravussin E et al..
Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese
and weight-reduced subjects.
Nat Med.
1995;
1
1155-1161
138
Mancuso P, Gottschalk A, Phare S M, Peters-Golden M, Lukacs N W, Huffnagle G B.
Leptin-deficient mice exhibit impaired host defense in gram-negative pneumonia.
J Immunol.
2002;
168
4018-4024
139
Ernst P, Gonzalez A V, Brassard P, Suissa S.
Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of
hospitalization for pneumonia.
Am J Respir Crit Care Med.
2007;
176
162-166
140
Calverley P M, Anderson J A, Celli B TORCH investigators et al.
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary
disease.
N Engl J Med.
2007;
356
775-789
141
Sin D D, Tashkin D, Zhang X et al..
Budesonide and the risk of pneumonia: a meta-analysis of individual patient data.
Lancet.
2009;
374
712-719
142
Welte T.
Inhaled corticosteroids in COPD and the risk of pneumonia.
Lancet.
2009;
374
668-670
143
Eurich D T, Sadowski C A, Simpson S H, Marrie T J, Majumdar S R.
Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
Am J Med.
2010;
123
47-53
144
Laheij R J, Sturkenboom M C, Hassing R J, Dieleman J, Stricker B H, Jansen J B.
Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.
JAMA.
2004;
292
1955-1960
145
Sarkar M, Hennessy S, Yang Y X.
Proton-pump inhibitor use and the risk for community-acquired pneumonia.
Ann Intern Med.
2008;
149
391-398
146
Bartlett J G, Mundy L M.
Community-acquired pneumonia.
N Engl J Med.
1995;
333
1618-1624
147
Rossman J S, Lamb R A.
Swine-origin influenza virus and the 2009 pandemic.
Am J Respir Crit Care Med.
2010;
181
295-296
148
Reed C, Angulo F J, Swerdlow D L et al..
Estimates of the prevalence of pandemic (H1N1) 2009, United States, April–July 2009.
Emerg Infect Dis.
2009;
15
2004-2007
149
Louie J K, Acosta M, Winter K California Pandemic (H1N1) Working Group et al.
Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1)
infection in California.
JAMA.
2009;
302
1896-1902
150
Ciancio B C, Meerhoff T J, Kramarz P et al..
Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 2007–8
had epidemiologic and clinical characteristics similar to co-circulating susceptible
A(H1N1) viruses.
Euro Surveill.
2009;
14(46). pii
19412
151
Fagiolo U, Amadori A, Cozzi E et al..
Humoral and cellular immune response to influenza virus vaccination in aged humans.
Aging (Milano).
1993;
5
451-458
152
Artz A S, Ershler W B, Longo D L.
Pneumococcal vaccination and revaccination of older adults.
Clin Microbiol Rev.
2003;
16
308-318
153
Gross P A, Hermogenes A W, Sacks H S, Lau J, Levandowski R A.
The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of
the literature.
Ann Intern Med.
1995;
123
518-527
154
Sisk J E, Moskowitz A J, Whang W et al..
Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people.
JAMA.
1997;
278
1333-1339
155
Butler J C, Breiman R F, Campbell J F, Lipman H B, Broome C V, Facklam R R.
Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations.
JAMA.
1993;
270
1826-1831
156
Simberkoff M S, Cross A P, Al-Ibrahim M et al..
Efficacy of pneumococcal vaccine in high-risk patients: results of a Veterans Administration
Cooperative Study.
N Engl J Med.
1986;
315
1318-1327
157
Ortqvist A.
Pneumococcal vaccination: current and future issues.
Eur Respir J.
2001;
18
184-195
158
Dear K, Holden J, Andrews R, Tatham D.
Vaccines for preventing pneumococcal infection in adults.
Cochrane Database Syst Rev.
2003;
(4)
CD000422
159
Evans S E, Scott B L, Clement C G et al..
Stimulated innate resistance of lung epithelium protects mice broadly against bacteria
and fungi.
Am J Respir Cell Mol Biol.
2010;
42
40-50
160
Nichol K L, Margolis K L, Wuorenma J, Von Sternberg T.
The efficacy and cost effectiveness of vaccination against influenza among elderly
persons living in the community.
N Engl J Med.
1994;
331
778-784
161
Ghendon Y Z, Kaira A N, Elshina G A.
The effect of mass influenza immunization in children on the morbidity of the unvaccinated
elderly.
Epidemiol Infect.
2006;
134
71-78
162
Reichert T A, Sugaya N, Fedson D S, Glezen W P, Simonsen L, Tashiro M.
The Japanese experience with vaccinating schoolchildren against influenza.
N Engl J Med.
2001;
344
889-896
163
Centers for Disease Control and Prevention (CDC) .
Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage: United States,
October–December 2009.
MMWR Morb Mortal Wkly Rep.
2010;
59
44-48
Keith C MeyerM.D. M.S.
Department of Medicine, Section of Allergy, Pulmonary, and Critical Care Medicine
University of Wisconsin School of Medicine and Public Health, K4/910 CSC 600 Highland
Ave., Madison, WI 53792
Email: kcm@medicine.wisc.edu